Food Deserts, Swamps Linked to Increased Risk of Death From Obesity-Related Cancers
US counties with food deserts or food swamps tend to have higher rates of death from obesity-related cancers, a study suggests.
Diagnosis & Disease Information
Second-Line Bevacizumab Provides No Benefit in Advanced Neuroendocrine Carcinoma
Adding bevacizumab to second-line chemotherapy does not improve survival in patients with advanced neuroendocrine carcinoma, a phase 2 study suggests.
Patients With Neuroendocrine Tumors May Value QOL Over Survival
Many patients with advanced neuroendocrine tumors may value preserving their quality of life over extending their survival, a small study suggests.
Proton FLASH Radiotherapy Deemed Feasible, Comparable to Conventional Dose Rate Radiotherapy
Proton FLASH radiotherapy is feasible, safe, and provides pain relief for cancer patients with bone metastases, according to a first-in-human trial.
Active Surveillance Feasible for Low-Risk Thyroid Cancer
Patients undergoing immediate surgery experience greater anxiety than patients in active surveillance.
Thyroid Cancer Often Detected in Asymptomatic Patients
Many thyroid cancers are discovered in patients who undergo surgery without thyroid-referable symptoms, an international study suggests.
Chemotherapy Doublets Remain Standard Care for Advanced Digestive Neuroendocrine Carcinoma
Etoposide plus cisplatin and irinotecan plus cisplatin remain the standard first-line chemotherapy options for advanced digestive neuroendocrine carcinoma, according to researchers.
Significant Financial Burden Associated With Thyroid Cancer Treatment, Survivorship
An analysis of studies in the literature sought to determine the financial burden patients with thyroid cancer incur from diagnosis, treatment, and surveillance.
Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Risk of Breakthrough COVID-19 Varies by Cancer Type
The risk of breakthrough SARS-CoV-2 infections was highest for liver cancer and lowest for thyroid cancer.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...